about
Minocycline: therapeutic potential in psychiatryAttenuation of oxidative stress, inflammation and apoptosis by minocycline prevents retrovirus-induced neurodegeneration in miceNovel frontiers in epilepsy treatments: preventing epileptogenesis by targeting inflammationIntracerebral hemorrhage in mouse models: therapeutic interventions and functional recoveryGlial modulators as potential treatments of psychostimulant abuseDelayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental strokeComprehensive behavioral testing in the R6/2 mouse model of Huntington's disease shows no benefit from CoQ10 or minocyclineProfile of minocycline neuroprotection in bilirubin-induced auditory system dysfunctionSelection of reference genes for quantitative real-time PCR in a rat asphyxial cardiac arrest model.Proton magnetic resonance spectroscopy reveals neuroprotection by oral minocycline in a nonhuman primate model of accelerated NeuroAIDSMicroglial depletion using intrahippocampal injection of liposome-encapsulated clodronate in prolonged hypothermic cardiac arrest in rats.Anti-inflammatory Actions of Adjunctive Tetracyclines and Other Agents in Periodontitis and Associated Comorbidities.Reductions in amyloid-beta-derived neuroinflammation, with minocycline, restore cognition but do not significantly affect tau hyperphosphorylation.Adjuvant therapy with minocycline for schizophrenia (The MINOS Trial): study protocol for a double-blind randomized placebo-controlled trial.COL-3, a chemically modified tetracycline, inhibits lipopolysaccharide-induced microglia activation and cytokine expression in the brain.Improving outcomes of neuroprotection by minocycline: guides from cell culture and intracerebral hemorrhage in miceInterleukin-6, produced by resident cells of the central nervous system and infiltrating cells, contributes to the development of seizures following viral infection.Prospects for minocycline neuroprotection.Mechanisms involved in dual vasopressin/apelin neuron dysfunction during aging.The benefit of minocycline on negative symptoms in early-phase psychosis in addition to standard care - extent and mechanism (BeneMin): study protocol for a randomised controlled trial.Anti-inflammatory treatments during the chronic phase of spinal cord injury improve locomotor function in adult mice.Novel mechanisms of central nervous system damage in HIV infection.Minocycline improves functional outcomes, memory deficits, and histopathology after endovascular perforation-induced subarachnoid hemorrhage in rats.Minocycline ameliorates LPS-induced inflammation in human monocytes by novel mechanisms including LOX-1, Nur77 and LITAF inhibition.Minocycline blocks lipopolysaccharide induced hyperalgesia by suppression of microglia but not astrocytes.Minocycline suppresses oxidative stress and attenuates fetal cardiac myocyte apoptosis triggered by in utero cocaine exposure.Minocycline induces protective autophagy in vascular endothelial cells exposed to an in vitro model of ischemia/reperfusion-induced injury.Selected gene profiles of stressed NSC-34 cells and rat spinal cord following peripheral nerve reconstruction and minocycline treatmentMinocycline: far beyond an antibiotic.Pregabalin as a neuroprotector after spinal cord injury in rats.A randomized double-blind, placebo-controlled trial of minocycline in children and adolescents with fragile x syndromeSystems Biology of Immunomodulation for Post-Stroke Neuroplasticity: Multimodal Implications of Pharmacotherapy and NeurorehabilitationEffects of minocycline on spatial learning, hippocampal neurogenesis and microglia in aged and adult mice.Mechanisms of minocycline-induced suppression of simian immunodeficiency virus encephalitis: inhibition of apoptosis signal-regulating kinase 1.A re-assessment of minocycline as a neuroprotective agent in a rat spinal cord contusion model.The importance of NAD in multiple sclerosisReduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast)Glial reactions and degeneration of myelinated processes in spinal cord gray matter in chronic experimental autoimmune encephalomyelitis.Minocycline protects motor but not autonomic neurons after cauda equina injury.Neuroprotection in the newborn infant
P2860
Q22241418-AA60663C-81D8-40DF-A1B5-30945BF28FDFQ24630229-41D0295C-790A-4996-BD2A-199BD46888F8Q26823386-FD06EA7C-BDEE-4FAC-BAF0-8D1477E9D62BQ26865843-2BD56961-FC11-48D1-A067-F01F53B55E61Q28307030-ABAB0CD2-4F54-4317-BBAC-1FB35DC8F12EQ28569418-A8EB19C1-B112-47A6-870D-5B1FC65FBC5DQ28748449-1B4706CA-4A23-4461-BF65-42A0AE22856CQ30471494-FF10B0B6-6494-4EE0-945E-4B0685524E94Q33337982-5A78905C-4EE2-45E4-8412-BF49DAB73F60Q33580220-51D6CA6C-1905-488B-872D-6CF1F44E4DF0Q33668297-24468D5C-EEA0-4DCA-942C-0DF294ACE42BQ33815397-AFD93324-F9B1-45A8-B740-A51B03E68819Q33856674-13F952D9-9DC4-4A50-A952-2891AB6C95B1Q34464608-603998DB-3EA4-4EE8-9147-A2A2458A5594Q34612475-9650F64D-FB33-4283-8BF8-3A887BA1EA8AQ34659673-3378E7E0-230E-4EC3-AD82-AE0AFD97AFC4Q35077723-B7E63481-9A77-48E2-96B4-0A33B1B0E268Q35079515-7D33C4DD-088E-44C2-9649-E4245FEC09F1Q35088157-3DF240B1-6A67-4574-8EC9-EAA4F0E824DDQ35154166-068ABEEB-4443-4359-99FD-032B4E6909D4Q35212541-C804D408-7EF6-4417-965F-FC8F72095AC6Q35557261-ECA30C92-6D73-4011-883F-D4446ECA3514Q35606184-FA4CFBC9-1540-4A0C-995D-0D7005D45EC6Q35840194-C5013001-F4D2-443F-9BE8-C7D4A23F76F2Q36179484-48F35DAB-3662-48A5-A188-D24D8BC4501DQ36429641-DF8169CD-5560-4C8D-B916-F82EDE7389B2Q36524535-84F0A590-5C78-4A01-9679-B5EE51C3C48FQ36825169-F81C05D6-4230-4020-AAA8-587501AE0B70Q36836358-DA4D5D40-5CA4-4F87-8D3B-288AFE7CE3D3Q36844010-42DBF79E-AED3-469A-9B2B-E7C757CE59F6Q36996583-C28A1133-5BDE-4F4F-AD21-4F67D99A2490Q37043237-7F2B7940-D667-4307-8149-982BA3ECCCB2Q37051935-3AE8F73A-2CD0-4D20-A2E5-80DD1F5CCB79Q37064542-AF1220F0-4331-4C9B-9ECF-25E9B18BFE18Q37097972-F0B07946-AA49-40B1-B68F-282E6BDFCA1DQ37118012-2F4B3730-9BAE-4203-8917-B7EB1E4780DBQ37143300-4482E441-7C5F-40DD-AEBE-1BAA3154919DQ37163112-EE9C8EA6-E465-4653-9333-D36E2BF63388Q37216519-78062473-AA5E-4C24-AF50-576256326E16Q37452432-402A280F-81D7-4CFB-98C6-7BBC8C07F849
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Minocycline as a neuroprotective agent.
@ast
Minocycline as a neuroprotective agent.
@en
type
label
Minocycline as a neuroprotective agent.
@ast
Minocycline as a neuroprotective agent.
@en
prefLabel
Minocycline as a neuroprotective agent.
@ast
Minocycline as a neuroprotective agent.
@en
P2093
P2860
P356
P1433
P1476
Minocycline as a neuroprotective agent.
@en
P2093
David P Stirling
John D Steeves
Kaveh M Koochesfahani
Wolfram Tetzlaff
P2860
P304
P356
10.1177/1073858405275175
P577
2005-08-01T00:00:00Z